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The aim of the study was to assess the diagnostic value of the sentinel node method in patients suffering from squamous cell
carcinoma of the upper aerodigestive tract. In 50 patients with oral, pharyngeal or laryngeal carcinomas staged N0 up to 50MBq
technetium-99m colloid were injected peritumorally. Sentinel nodes were localised using a g-probe in the setting of an elective neck
dissection. Pathological findings of sentinel nodes and corresponding neck specimens were compared. In 46 patients sentinel nodes
were detected. Of these 34 patients were free of metastatic disease in the sentinel nodes and in the neck specimens. In 12 patients
clinically occult metastases were found in the sentinel nodes. Three metastases were detected only after additional sectioning of the
sentinel nodes. In four patients, a sentinel lymph node could not be localised. Our results support the sentinel node concept in head
and neck cancer and a definition of the sentinel nodes as the three nodes with the highest activity. Careful clinical staging of the neck
and thorough pathological evaluation of the sentinel nodes are necessary to avoid false-negative results.
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Surgical therapy of the lymphatic basins in head and neck
malignancies has been evolved from radical neck dissection to
modified radical neck dissection in order to reduce the morbidity of
the procedure and to preserve as much function and quality of life
as possible for the patient while still maintaining an oncologic
sound result (Sua ´rez, 1962). With the same objective proponents of
a further limitation favour a selective neck dissection in the
presence of initial cervical disease (Traynor et al, 1996; Ambrosch
et al, 2001). While there are efforts to reduce the surgical approach
in the presence of metastases, there is even more reason to do so if a
neck has been staged N0. The problem arises from the fact that
current staging methods cannot reliably exclude small metastases.
A risk of occult metastatic disease exceeding 15–20%, therefore, is
considered an indication for elective neck dissection (Steiner and
Hommerich, 1993; Pitman et al, 1997). If occult metastases are
detected in the neck dissection specimen, adjuvant radiotherapy
will usually be indicated while in case of a neck without metastatic
disease there are no therapeutic consequences. However, patients
experience a loss of quality of life due to the morbidity of the neck
dissection. To preserve quality of life while aiming for an oncologic
sound result, the sentinel lymph-node concept was established.
Sentinel lymph nodes are defined as the first nodes to drain a
tumour. Thus, they carry the highest risk of metastatic disease.
Based on this apriority, the hypothesis of the sentinel node concept
is that the oncologic status of the sentinel node has diagnostic value
for the total lymphatic basin. The intriguing idea is that a sentinel
node free of tumour may make an elective lymphonodectomy of the
lymphatic basin unnecessary. The sentinel node concept has been
introduced in malignant melanomas and breast cancer (Morton
et al, 1992; Giuliano et al, 1994). While there have been early studies
on malignant melanomas in the head and neck (Morton et al, 1993),
there is only limited experience in head and neck squamous cell
carcinoma. It was the aim of this study to assess the diagnostic
value of the sentinel node method in head and neck cancer.
PATIENTS AND METHODS
Patients
From May 2000 until May 2003, 40 male and 10 female patients
with previously untreated squamous cell carcinomas of the upper
aerodigestive tract were included in this study. The study was
conducted in accordance to the Revised Declaration of Helsinki
(2000). Informed written consent was obtained from each patient.
Tumours were located in the larynx in 12 cases. In all, 11 patients
suffered from carcinoma of the tonsil, 10 patients of the mobile
tongue, eight of the floor of the mouth, three of the base of the
tongue, four of the palate, one of the dorsal oropharyngeal wall and
one of the hypopharynx (Table 1). One more patient with a tumour
of the base of the tongue and three more patients with laryngeal
tumours who were all initially thought feasible for the study were
not included because it was not possible to expose the caudal rim
of the tumours and to perform a peritumoral injection of the
tracer. Thus, the patients received only part of the injections.
Staging of the neck was based on ultrasound examination of the
neck. In 19 patients, an ultrasound-guided fine-needle aspiration
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ycytology was performed. In each case, the N0-status of the neck
was confirmed as a prerequisite for study inclusion.
Methods
Up to a total of 50MBq
99Tc-colloid (SolcosNanocoll, Solco,
Basel, Switzerland) dissolved in 0.2ml saline solution was injected
peritumorally with a minimum of four injections depending on the
location and size of the tumour. Particle size of the tracer was less
than 80nm in diameter. The injection was given on the day of
resection of the primary tumour and elective neck dissection. In 11
patients with accessible tumours peritumoral injection was given
preoperatively and lymphoscintigraphy was performed. Planar
images were acquired using a large-field-of-view-gamma camera
equipped with a LEAP-collimator (Gammadiagnost Tomo, Philips,
Hamburg, Germany). The sequence for the first 10min was 30s per
frame from a frontal, left or right lateral view. Then, 5-min images
were acquired up to 30min post injection from different views.
Lymphatic drainage was assessed by visual inspection. Lymph
nodes accumulating tracer were marked on the skin. Initially, only
in cases with difficult to access tumours such as carcinomas of the
base of the tongue, larynx and in some tumours of the oropharynx
injection was performed intraoperatively. After May 2002,
all tumours were injected intraoperatively. In these cases a
Table 1 Patient characteristics
ND
Number and level
of SLNs
Number and level of
SLNs with tumor Level of metastases
No.
Site of
primary Midline T-status Ipsi Contra Ipsi Contra Ipsi Contra pN-status Ipsi Contra
1 Tongue No 1 I–III I-III II, 8xIII III 0
2 Larynx No 3 II–IV II-IV II 0 0
3 Larynx No 3 II–IV II-IV I, II, III 0 0
4 Larynx No 3 II-IV II-IV II, 2xIII, 2xV 0 0
5 Tongue No 2 I–III 4xIII III 1 III
6 Tonsil No 2 I–IV I-IV 3xI, 3xIII, 5xV 0 I 1 I
7 Larynx No 3 I–III II 0
8 Tongue No 2 I–IV II, 5xIII, IV, 1xIV 0
9 Larynx No 3 I–V II-IV I, II, 2xIII 0 0
10 Tonsil No 4 I–V 5xII 0
11 Tonsil No 2 I–V I, 2xII 0
12 FOM No 2 I–III I 0
13 BOT No 3 I–IV II, V II 1 II
14 FOM No 2 I–V 4xII 0
15 Tongue No 2 I–IV II, III, V 0
16 Larynx No 1 I–IV II, III 0
17 Larynx No 3 I–III I-III II II 0
18 Tonsil No 2 I–IV 2xII 2xII 2b 2xII
19 Tonsil No 2 I–IV II II 2b I, 2xII, III
20 Tonsil No 1 I–V II 0
21 Tongue No 1 I–IV 4xII II 1 II
22 Tongue No 2 I–IV 4xII, 2xIII 2xII 2b 2xII
23 FOM Yes 2 I–IV I-IV II 2xII, 3xIII 0
24 Larynx Yes 3 I-III I-III III II, 2xIII 0
25 Palate Yes 2 II–III II-III III II 0
26 BOT No 1 I–IV I-IV I, II, 2xIII 0 0
27 Larynx No 3 II–IV II-IV 4xII 0 0
28 Tongue No 2 I–III I, 2xIII 0
29 Tongue No 1 I–III 2xIII 0
30 FOM Yes 2 I–III I–III II II 0
31 FOM Yes 3 I–IV I–III 2xII I, II 0
32 BOT No 3 II–IV II–IV 2xII 0 0
33 Tonsil No 2 I–IV II II 2b 3xII
34 Oropha Yes 2 II–V II–V II II 0
35 FOM No 2 I–IV I–IV I, II 0 0
36 Larynx No 1 II–IV 2xIII 0
37 Palate Yes 3 II–IV II–IV II 2xII 1 2c II
38 Tonsil No 2 I–IV 0 0
39 Tongue No 2 I–III 3xII, 3xIII II, III 2b II, III
40 Tonsil No 2 II–IV II II 1 II
41 Tongue No 2 I–IV I, II, III III 2b 2xI, III
42 Tongue No 3 I–III II, III, IV 0
43 Palate No 2 II–III 0 0
44 Tonsil No 2 II–III 2xII 0
45 FOM No 1 I–III I–II I, II 0
46 Hypopharynx No 4 II–IV II–IV II 0
47 Palate No 2 II–III 0 1 II
48 Larynx Yes 3 II–III II–III II, 2xIII 0
49 Larynx No 3 II–III 0 0
50 Tonsil No 1 II–IV II, 2xIII, IV 0
Midline signifies a tumour crossing the midline. FOM¼floor of the mouth; BOT¼base of the tongue; oropha¼posterior oropharyngeal wall; ND¼levels of neck dissection;
Ipsi¼ipsilateral; Contra¼contralateral; SLN¼sentinel lymph node. Roman numbers indicate the levels of the neck.
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operatively was not possible. In patients with laryngeal tumours a
microlaryngoscopy was performed to expose the tumour. Peritu-
moral injection was given by using a butterfly-cannula.
For intraoperative detection of the sentinel lymph nodes,
cutaneous flaps were raised and the sternomastoid muscle was
retracted. A straight 14-mm diameter g-probe (Navigator GPS,
RMD, Watertown, MA, USA) was used to localise lymph nodes
accumulating tracer. Counts of the primary tumour, background
activity and sentinel lymph nodes were documented for a 10-s-
period each by the g-probe. All lymph nodes accumulating activity
were harvested and initially termed sentinel nodes. A definition of
the true sentinel node was to be based on the results. After separate
resection of the sentinel lymph nodes neck dissection was
continued. It was carried out unilaterally in 39 patients and
bilaterally in 21 patients. The extent of the neck dissection was
depending on location and size of the primary tumour. In three
patients with a tumour not crossing the midline sentinel nodes
were observed on both sides of the neck. A bilateral neck
dissection had been determined before the sentinel node
procedure. Therefore no change in policy was necessary. If
feasible, the primary tumour was excised before neck dissection
in order to reduce the shine-through and scatter from the injection
site, which can significantly hinder the detection of the sentinel
lymph node. Location of sentinel lymph nodes, metastases and
extent of neck dissection are described according to the
terminology of the American Academy of Otolaryngology – Head
and Neck Surgery (Robbins et al, 2002).
Neck dissection specimens and sentinel nodes were fixed in 10%
neutral buffered formalin. For pathological examination, nodes
were bisected along the axis. All nodes including sentinel lymph
nodes were evaluated by a hematoxylin–eosin (H&E)-stained
single section. If the single slices of the sentinel lymph nodes were
free of tumour cells, they were further examined by step serial
sections in 2mm intervals in 18 patients. Of each block three
sections were cut. One slice was stained with H&E and a second
one immunohistochemically with cytokeratin antibody Lu5 (BMA,
Augst, Switzerland). Results of the pathohistological examination
of the sentinel lymph nodes and the respective neck dissection
specimens were compared.
RESULTS
In 46 out of 50 patients, there was a lymphatic drainage of the
radiocolloid into at least one sentinel lymph node. In four patients,
a sentinel lymph node could not be detected. Of 42 patients with a
tumour not crossing the midline, 35 had an ipsilateral and three a
bilateral drainage into sentinel lymph nodes while four did not
reveal any sentinel nodes. Of eight patients with a tumour crossing
the midline, seven had a bilateral and one a unilateral lymphatic
drainage. The number of lymph nodes accumulating tracer and
being biopsied intraoperatively varied from 1 to 11. The average
number of lymph nodes accumulating the tracer was 3.2 (Table 1).
There was no correlation between time interval between injection
of the tracer and localisation of the sentinel nodes to the number of
nodes detected.
Three of 11 patients with preoperative lymphoscintigraphy did
not reveal a lymphatic drainage during scintigraphy, while in these
three patients radiolabelled sentinel lymph nodes were detected
intraoperatively with the g-probe. In two of them an occult
metastasis was found. In the remaining eight patients, a lymphatic
drainage was observed by scintigraphy. The drainage into the
levels of the neck was identical to the location of sentinel lymph
nodes detected with the g-probe. In six cases, however, there were
more sentinel nodes detected with the probe than visualised by
scintigraphy.
In 34 patients pathohistological examination did neither show
occult metastases in the sentinel nodes nor in lymph nodes of the
neck dissection specimens. In 12 patients at least one sentinel
lymph node was found to harbour occult metastastic disease. In
nine of these patients metastases in the sentinel lymph nodes were
the only ones, whereas in three patients additional metastases were
found in nonsentinel lymph nodes. Thus, the status of the neck
had to be changed from N0 to pN1 in five patients, to pN2b in six
patients and due to a contralateral metastasis to pN2c in one
patient. All sentinel nodes containing occult metastases were
within the first five nodes of highest activity in each patient
(Table 2). None of the patients with tumour-free sentinel lymph
nodes revealed metastases in nonsentinel lymph nodes.
In three patients without detectable sentinel lymph nodes, no
metastases were found by pathohistologic examination. In one
patient without accumulation of the tracer in lymph nodes a single
metastasis was detected in the neck dissection specimen.
In two of 12 patients, occult metastases were detected only after
additional sections had been stained with H&E. In one patient, the
metastasis was found by immunohistochemical staining only.
Of the four patients in whom a peritumoral injection was not
possible and who received only part of the injection, two patients
with laryngeal carcinomas were staged pN0 after pathohistologic
examination. In the remaining two patients lymph nodes
accumulating tracer were tumour-free whereas in each case a
node without tracer accumulation harboured metastatic disease.
DISCUSSION
The sentinel node concept offers the chance to stage the neck with
less morbidity than an elective selective neck dissection. Attempts
in assessing the diagnostic value of the sentinel node by fine-
needle aspiration cytology offering the least possible morbidity,
though at first promising, were not successful (Colnot et al, 2001;
Table 2 Background activity and count rate of radiolabelled sentinel lymph nodes
No. Background counts 1. SLN 2. SLN 3. SLN 4. SLN 5. SLN 6. SLN 7. SLN 8. SLN 9. SLN 10. SLN 11. SLN
53 73698 2734 1368 750
6 12 1590 1407 1364 665 519 404 403 346 274 265 221
13 40 181 160
18 71 990 578
19 17 121
21 5 1975 204 142 91
22 6 1250 945 542 112 98 76
33 22 744
37 18 192 66 51
39 2 90 89 50 45 37 12
40 4 41
Lymph nodes marked in bold letters signify occult metastatic disease. SLN¼sentinel lymph node.
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reliably detect occult metastatic disease as the sample of the
sentinel lymph node is too small. Achieving a valid diagnosis
mandates a pathohistological examination of a complete sentinel
node. In order to determine the diagnostic value of the sentinel
lymph-node concept, we compared the pathohistological results of
sentinel nodes with the respective neck dissection specimens.
In our group of patients, the pathological exclusion of occult
metastases in sentinel lymph nodes was predictive for the
pathological status of the neck in each patient. Based on the
limited number of patients in this study, the sentinel lymph node
seems to have a high diagnostic value in head and neck cancer.
This is in accordance with the literature. The first biopsy of a
radiolabelled sentinel lymph node in head and neck cancer was
performed by Alex and Krag (1996). Initial investigations of the
sentinel lymph-node concept in head and neck cancer were
disappointing using blue dye only (Alex and Krag, 1996; Pitman
et al, 1998; Shoaib et al, 1999). Studies applying a radiolabelled
tracer with or without additional blue dye, however, were
promising. The majority of the studies reported results favouring
the sentinel lymph-node concept (Koch et al, 1998; Shoaib et al,
1999, 2001; Alex et al, 2000; Zitsch et al, 2000; Mozzillo et al, 2001;
Stoeckli et al, 2001, 2002; Barzan et al, 2002; Werner et al,
2002a,b). Groups who worked with blue dye report of an
extravasation of the blue dye into the tissue (Pitman et al, 2002).
Other authors detected stained sentinel nodes only in a minority of
their patients (Stoeckli et al, 2001). Additionally, blue dye will stain
the area around the primary tumour. This hinders a resection of
the primary tumour and might alter the absorption of the laser
energy that is frequently used to resect oral, pharyngeal and
laryngeal tumours. Therefore, most groups in contrast to groups
treating malignant melanomas or breast cancer prefer a radioactive
tracer without using blue dye.
We excluded four patients from our study in whom a
peritumoral injection of the caudal rim of the tumour was not
possible. Since the tracer had already been injected, nodes
accumulating tracer were localised. Pathohistological comparison
revealed occult metastatic disease in two of the patients. However,
the nodes that had accumulated the tracer were free of metastases.
Thus, if a complete peritumoral injection of the tracer is not
possible, the patient is not eligible for the sentinel node method.
In four of our patients, no sentinel node could be detected.
Reasons might be a wrong technique by injecting the tracer too
deep into the tissue not close enough to the mucosa. Another
reason might be that in-transit metastases diverted or in this case
blocked the drainage of the radiocolloid into the sentinel node
(Civantos et al, 2003).
In 10 of 13 patients with occult metastases, the initial H&E
staining was sufficient to detect the metastases. In two of the
patients, however, they were discovered exclusively after additional
sections had been stained with H&E. In another case, tumour cells
were found by immunohistochemical staining only. An intensive
sectioning and standard H&E staining as well as immunohisto-
chemical staining will reveal more metastases than standard single-
block examination of a lymph node (Ambrosch et al, 1995; van den
Brekel et al, 1996). Thus, performing a sentinel node-biopsy and
basing the therapy of the neck on the status of the sentinel lymph
node mandates an intensive and profound patho- and immuno-
histochemical work-up.
In one patient 10 and in another patient 11 radioactive lymph
nodes were found. It is obvious that not all these nodes were
sentinel lymph nodes. A high number of nodes accumulating
activity poses a problem as the aim of the sentinel node concept is
to keep the surgical morbidity to a minimum. Yet, also in other
studies up to nine nodes accumulating tracer have been detected
(Alex et al, 2000; Shoaib et al, 2001). There have been different
approaches to limit the number of nodes to be biopsied by
defining the sentinel lymph node by its activity. Alex et al (2000)
suggested that an activity three times higher than the background
should classify a sentinel lymph node. Zitsch et al (2000) adopted a
definition used in malignant melanomas defining the sentinel node
as having two times the background activity count rate. Werner
et al (2002a) characterised sentinel lymph nodes as the three nodes
with the highest activity emitting at least 10 times the background
counts. As depicted in Table 2, all sentinel lymph nodes with occult
metastases were among the five nodes with the highest activity.
Yet, even if we had limited ourselves to harvesting the three nodes
with the highest activity, we still would have detected all patients
with occult metastatic disease. Thus, defining the sentinel nodes as
the three nodes with the highest activity seems to be sufficient to
reduce the number of nodes to be resected while achieving an
oncologic sound result.
Counts of the background and of the sentinel nodes varied
considerably. This might be due to individual differences, although
the technique has been standardised as described. Depth of
injection might differ slightly resulting in a reflux of the tracer out
of the tissue causing a higher background from the pharynx. Also
less tracer will reach the lymph nodes. Patients 39 and 40 had small
tumours. Therefore, less than 50MBq was injected. Consequently,
this might result in a reduced count both of the sentinel nodes and
of the background. No correlation of the varying counts in respect
to time interval between injection and detection of the sentinel
nodes was found. However, since sentinel nodes are defined as the
three nodes with the highest activity and not in relation to the
average counts of all patients differences to the average do not
have an impact on the individual patient.
Preoperative lymphoscintigraphy did not improve the proce-
dure of identifying the sentinel nodes: in two patients without
scintigraphic drainage sentinel nodes containing occult metastases
were localised by the g-probe. In the other patients more
radiolabelled nodes were detected intraoperatively by the g-probe
than visualised by scintigraphy. In these cases, scintigraphy did
not reduce the number of nodes to be biopsied as all were located
in the same levels of the neck as the nodes visualised
preoperatively. Thus, there seems to be little help by preoperative
lymphoscintigraphy and we do not apply it on a regular basis any
longer. An argument in favour of preoperative lymphoscintigraphy
is the existence of aberrant drainage patterns to the contralateral
side of the neck. However, careful percutaneous scanning with the
g-probe should detect radiolabelled lymph nodes there, too.
The average incidence of occult metastatic disease was 26%
based on staging by ultrasound and ultrasound-guided fine-needle
aspiration cytology. These results are comparable to the findings of
other groups also applying radiological criteria for staging
(Stoeckli et al, 2001; Barzan et al, 2002; Werner et al, 2002a).
The better the staging methods are in detecting small metastases,
the less occult metastases will be overlooked and the more valuable
will be the impact of an additional sentinel lymph-node procedure.
Consequently, it is important not to replace standard staging
methods by the sentinel lymph-node concept, but to perform it in
addition to the best possible staging procedures.
In the present group, no patient with tumour-free sentinel nodes
was found to have a metastasis in a nonsentinel lymph node.
Therefore, one could argue that if we had performed a sentinel
biopsy only, an elective neck dissection could have been avoided in
34 of our 50 patients. Yet, data are too limited to permit this step.
So far, only Ross et al (2002) have reported on a study of a true
biopsy of the sentinel lymph node without elective neck dissection.
In case of occult metastatic disease, therapeutic neck dissection is
performed. However, so far, there have been no sufficient follow-
up data. A validation of the sentinel lymph-node method mandates
that patients with a mere biopsy of the sentinel nodes should have
equal regional control rates as patients after elective neck
dissection. The consequence of a tumour-positive sentinel lymph
node has to be discussed, too. A subsequent therapeutic neck
dissection will be delayed by several days until sentinel nodes have
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Revision neck dissection will cause additional morbidity.
Alternatively, radiotherapy could be applied. This again would
cause severe morbidity. Intraoperative examination of the sentinel
nodes would enable an instant decision whether or not to perform
a therapeutic approach to the neck and to avoid a second surgical
step. Frozen section examination of the sentinel lymph nodes has
been performed in breast cancer and malignant melanomas.
However, sensitivity especially for micrometastases is low and
therefore frozen section examination is not recommended in these
tumours (Turner et al, 1999; Koopal et al, 2000). Likewise,
Civantos et al (2003) discovered only six of 10 occult metastases of
squamous cell carcinomas of the oral cavity by frozen section
examination. Thus, at present, there are still a number of problems
to be solved before sentinel lymph-node biopsy can be integrated
into clinical routine. Further studies with a combined sentinel
node biopsy and elective neck dissection will have to clarify
whether or not early metastases can be detected by sentinel node
biopsy only. If this can be proven, more studies will be necessary
to determine whether or not regional control after sentinel biopsy
is equivalent to elective neck dissection and whether or not
sentinel node biopsy with a possible secondary therapeutic neck
dissection results in less morbidity than a primary limited selective
elective neck dissection.
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